Ledger.Open graph →
SEC Form D · filed February 28, 2025

Aligos Therapeutics, Inc

Offering
$105.0M
Sold
$105.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
South San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

James P. Scopa · South San Francisco, CADirectorCarole P. Nuechterlein · South San Francisco, CADirectorLawrence M. Blatt · South San Francisco, CAExec · DirectorLesley A. Calhoun · South San Francisco, CAExecBridget P. Martell · South San Francisco, CADirectorJulian P. Symons · South San Francisco, CAExecK. P. Hirth · New Haven, CTDirectorLesley A. Calhoun · South San Francisco, CAExecBridget P. Martell · South San Francisco, CADirectorCarole P. Nuechterlein · South San Francisco, CADirectorJames P. Scopa · South San Francisco, CADirectorLawrence M. Blatt · South San Francisco, CAExec · DirectorCarla A. Harris · New York, NYExecMargarita P. Chavez · South San Francisco, CADirectorHeather P. Preston · South San Francisco, CADirectorHardean P. Achneck · South San Francisco, CAExecTony Wood · Vancouver, British Columbia, CanadaExecJohn Seaberg · Vancouver, British Columbia, CanadaExec · DirectorAnindya Bose · Alpharetta, GAExecOrville Gordon · Alpharetta, GADirectorRich Cannon · Alpharetta, GADirectorLarry Mohl · Alpharetta, GADirectorMargarita P. Chavez · South San Francisco, CADirectorK. P. Hirth · South San Francisco, CADirectorHeather P. Preston · South San Francisco, CADirectorHardean P. Achneck · South San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗